NantKwest (NK) IPO Prices at $25, Above Expected Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
NantKwest Announces Pricing of Initial Public Offering
July 28, 2015 1:38 AM EDTCULVER CITY, Calif.--(BUSINESS WIRE)-- NantKwest, Inc. (formerly Conkwest, Inc.), a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases, announced today the pricing of its initial public offering of 8,288,000 shares of its common stock at a price to the public of $25.00 per share. All of the shares are being offered by NantKwest. The shares are expected to begin trading on The Nasdaq Global Select Market on July 28, 2015, under the symbol "NK." In addition, NantKwest has granted the underwriters... More



